You have run a regression of monthly returns on Am- gen, a large biotechnology rm, against monthly returns on the S&P 500 Index, and come up with the following output:

Rstock = 3.28% + 1.65 RMarketR2 = 0.20

The current one-year Treasury bill rate is 4.8% and the current thirty-year bond rate is 6.4%. The rm has 265 million shares outstanding, selling for $30 per share.

a. What is the expected return on this stock over the next year?

b. Would your expected return estimate change if the purpose was to get a discount rate to analyze a thirty-year capital budgeting project?

c. An analyst has estimated correctly that the stock did 51.10% better than expected annually during the pe- riod of the regression. Can you estimate the annual- ized risk-free rate that she used for her estimate?

d. The rm has a debt-to-equity ratio of 3% and faces a tax rate of 40%. It is planning to issue $2 billion in new debt and acquire a new business for that amount, with the same risk level as the rms exist- ing business. What will the beta be after the acquisi- tion?